Allergan's besieged Restasis patents get smacked again, this time in retailer antitrust suit

17th May 2018 Uncategorised 0

Allergan has already faced heaps of scrutiny for its strategies to protect blockbuster eye drug Restasis from generic competition, but it’ll have to defend itself against a new group of plaintiffs¬†now that four retail pharmacies have launched a lawsuit.

More: Allergan's besieged Restasis patents get smacked again, this time in retailer antitrust suit
Source: fierce